Jacques B Armand

Title: Jacques B Armand: Innovator in Immunomodulating Medications

Introduction

Jacques B Armand is a notable inventor based in St Germain, France. He has made significant contributions to the field of immunology through his innovative work on immunomodulating medications. His research focuses on the development of treatments that leverage the unique properties of human immunoglobulin G (IgG).

Latest Patents

Jacques B Armand holds a patent for an immunomodulating medication based on Fc fragments of human IgG. This medication is characterized by its composition, which consists of Fc fragments of human IgG or their analogues. Importantly, it is free of intact IgG and/or Fab fragments, or contains no more than 2% by weight of the latter concerning the total weight of Fc, Fab, and IgG. The analogues of Fc fragments include all fragments or subfragments of Fc, as well as synthetic or semisynthetic peptides containing peptide sequences present in the Fc fragment. These innovations are crucial for advancing therapeutic options in immunology.

Career Highlights

Jacques B Armand is associated with Institut Merieux, a prominent research institution known for its focus on health and biotechnology. His work at this institution has allowed him to explore and develop groundbreaking medical solutions that address various health challenges.

Collaborations

One of his notable collaborators is Edgardo D Carosella, with whom he has worked closely to advance their research in immunology. Their partnership has contributed to the development of innovative therapies that have the potential to improve patient outcomes.

Conclusion

Jacques B Armand's contributions to the field of immunology through his patent on immunomodulating medications highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments that utilize the unique properties of human IgG.